92545 ⎘
Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
DIVERSITY-ORIENTED POLYMERS OF INTRINSIC MICROPOROSITY AND USES THEREOF
#2SALT OF DEMETHYL TRAMADOL AND USE THEREOF
#3Metabolism resistant fenfluramine analogs and methods of using the same
#4Diversity-oriented polymers of intrinsic microporosity and uses thereof
#5Substituted Phenethylamines with Serotoninergic and/or Norepinephrinergic Activity
#6Compounds for use in the elimination of pluripotent stem cells
#7Metabolism resistant fenfluramine analogs and methods of using the same
#8Process for preparation of O-Desmethyltramadol and salts thereof
#9Substituted Phenethylamines with Serotoninergic and/or Norepinephrinergic Activity
#10Crystal form of dezocine and preparation method therefor
#11Conjugate of dezocine and polyethylene glycol
#12Dezocine analogue
#13Metabolism resistant fenfluramine analogs and methods of using the same
#14COMPOSITIONS COMPRISING BIOREVERSIBLE DERIVATIVES OF HYDROXY N-SUBSTITUTED-2-AMINOTETRALINS, AND RELATED DOSAGE FORMS
#15(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
#16Diphenethylamine derivatives which are inter alia useful as analgesics and method for their production
#17Solid forms of desvenlafaxine
#18Chiral diamine compounds for the preparation of chiral alcohols and chiral amines
#19Serotonin receptor-targeting compounds and methods
#20(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
#21Solid Forms Comprising(-)-O-Desmethylvenlafaxine And Uses Thereof
#22Cyclopropylamine derivatives useful as LSD1 inhibitors
#23Methods of treating a subject using bioreversible derivatives of hydroxy n-substituted-2-aminotetralins
#24Compositions comprising bioreversible derivatives of hydroxy N-substituted-2-aminotetralins, and related dosage forms
#25DERIVATIVES OF (-)-VENLAFAXINE AND METHODS OF PREPARING AND USING THE SAME
#26Lysine demethylase inhibitors for myeloproliferative disorders
#27Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
#28Pharmaceutical compositions with attenuated release of phenolic opioids
#29LYSINE DEMETHYLASE INHIBITORS FOR INFLAMMATORY DISEASES OR CONDITIONS
#30Lysine demethylase inhibitors for diseases and disorders associated with Flaviviridae
#31Polymorphs of 4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenyl 4-methylbenzoate hydrochloride, methods of preparing the same and use of the same
#32Benzocycloheptane and benzoxepine derivatives
#33LYSINE DEMETHYLASE INHIBITORS FOR MYELOPROLIFERATIVE OR LYMPHOPROLIFERATIVE DISEASES OR DISORDERS
#34Methods of using derivatives of (−)-venlafaxine
#35Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
#36Analgesic compounds, methods, and formulations
#37SHIP1 modulators and related methods
#38Cyclopropylamine derivatives useful as LSD1 inhibitors
#39Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
#403-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
#41Benzocycloheptane and benzoxepine derivatives
#42Polymomorph of desvenlafaxine benzoate
#43Derivatives of venlafaxine and methods of preparing and using the same
#44Aminotetraline derivatives
#45Polymorphic forms of O-desmethyl-venlafaxine succinate
#46Process for the preparation of O-desmethyl-venlafaxine and salts thereof
#47Methods of using derivatives of (−)-venlafaxine
#48Process for the preparation of O-desmethyl venlafaxine and intermediate for use therein
#493-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
#50Pharmaceutical salts
#51Salts of desvenlafaxine and a method of their preparation
#52Process for the Preparation of Substituted 1-aminomethyl-2-phenyl-cyclohexane Compounds
#53Pharmaceutical compositions with attenuated release of phenolic opioids
#54PROCESS FOR THE PREPARATION OF O-DESMETHYLVENLAFAXINE
#551-Phenyl-2-DimethylaminomethylCyclohexane Compounds and Therapies for Depressive Symptoms, Pain and Incontinence
#56HCI POLYMORPHS OF 3-((2-(DIMETHYLAMINO)METHYL (CYCLOHEX-1-YL))PHENOL
#57Crystalline salts and/or co-crystals of O-desmethyltramadol
#58Process for the preparation of rotigotine
#59O-DESMETHYLVENLAFAXINE SUCCINATE POLYMORPH & PROCESS FOR PREPARING THEREOF
#60Process for the preparation of optically active (S)-(−)-2-(N-propylamino)-5-methoxytetraline and (S)-(−)-2-(N-propylamino)-5-hydroxytetraline compounds
#61PROCESS FOR PREPARING O-DESMETHYLVENLAFAXINE
#62SOLID STATES OF O-DESMETHYLVENLAFAXINE SALTS
#63Salts of O-desmethyl-venlafaxine
#64SOLID FORMS OF (±)-O-DESMETHYLVENLAFAXINE SALTS
#65Benzocycloheptane and benzoxepine derivatives
#66Process for producing 1-[2-(dimethylamino)-1-(4-phenol)ethyl]cyclohexanol
#67Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
#68Substituted tetralins as selective estrogen receptor-β agonists
#69O-DESMETHYLVENLAFAXINE AND BAZEDOXIFENE COMBINATION PRODUCT AND USES THEREOF
#70Process for the preparation of O-desmethylvenlafaxine succinate polymorphic forms
#71PROCESS FOR SYNTHESIZING DESVENLAFAXINE FREE BASE AND SALTS OR SOLVATES THEREOF
#72PROCESS FOR THE PREPARATION OF PHENETHYLAMINE DERIVATIVES
#73HCl Polymorphs of 3-((2-(Dimethylamino)methyl-(cyclohex-1-yl))phenol
#74POLYMORPHS OF O-DESMETHYL VENLAFAXINE SUCCINATE
#75NOVEL HYDRATE FORM OF O-DESMETHYL VENLAFAXINE SUCCINATE
#76Method for preparation of o-desmethylvenlafaxine using polythiolates
#77ENANTIOMERS OF O-DESMETHYL VENLAFAXINE
#78Substantially pure O-desmethylvenlafaxine and processes for preparing it
#79PHARMACEUTICAL SALTS
#80O-desmethylvenlafaxine Cocrystals
#81Processes for the preparation of odesmethylvenlafaxine, free from its dimer impurities
#82Process for producing 6-dimethylaminomethyl-phenyl-cyclohexane-1,3-diols
#83Crystal forms of O-desmethylvenlafaxine fumarate
#843-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
#85Processes for the synthesis of O-Desmethylvenlafaxine
#86PROPARGYLAMINO INDAN DERIVATIVES AND PROPARGYLAMINO TETRALIN DERIVATIVES AS BRAIN-SELECTIVE MAO INHIBITORS
#87Processes for the synthesis of O-desmethylvenlafaxine
#88SUBSTITUTED CYCLOHEXANOLS
#89Methods for Preparing O-Desmethylvenlafaxine
#90Novel Succinate Salt of O-Desmethyl-Venlafaxine
#91Crystal forms of O-desmethylvenlafaxine succinate
#92Solid forms comprising (-)-O-desmethylvenlafaxine and uses thereof
#93Derivatives of venlafaxine and methods of preparing and using the same
#94Isolated hydroxy and n-oxide metabolites and derivatives of O-desmethylvenlafaxine and methods of treatment
#95HCI polymorphs of 3-((2-(dimethylamino)methyl(cyclohex-1-yl)) phenol
#96Processes for preparing solid states of O-desmethylvenlafaxine succinate
#97SUBSTITUTED PHENETHYLAMINES WITH SEROTONINERGIC AND/OR NOREPINEPHRINERGIC ACTIVITY
#98Processes for the synthesis of O-desmethylvenlafaxine
#99Crystalline polymorphs of desvenlafaxine succinate and their preparations
#100Dosage forms of O-desmethylvenlafaxine
#101Crystal forms of O-desmethylvenlafaxine
#102Substantially pure O-desmethylvenlafaxine and processes for preparing it
#103Process for making desvenlafaxine
#104Production method of phenylethanolamine compound, and its intermediate
#105Methods for preparing O-desmethylvenlafaxine
#106Enantiomers of O-desmethyl venlafaxine
#107Succinate salt of O-desmethyl-venlafaxine
#108Highly selective serotonin and norepinephrine dual reuptake inhibitor and use thereof
#109Modulators of the glucocorticoid receptor
#110O-desmethylvenlafaxine and bazedoxifene combination product and uses thereof
#111Methods of using derivatives of (-)-venlafaxine
#112Salts of (-)-O-desmethylvenlafaxine
#113Enantiomers of O-desmethyl venlafaxine
#114Formate salt of O-desmethyl-venlafaxine
#115Enantiomers of O-desmethyl venlafaxine
#116N-bisaryl- and n-aryl-cycloakylidenyl-αhydroxy-and α-alkoxy acid amides
#117O-desmethylvenlafaxine and methods of preparing and using the same
#1181-Phenyl-2-dimethylaminomethyl cyclohexane compounds and therapies for depressive symptoms, pain and incontinence
#119Pharmaceutical salts
#120Succinate salt of O-desmethyl-venlafaxine